Ellie Wishart, BSc, Real World Evidence Manager at Ecolab discusses the role of industry partners in the Clean Hospitals initiative and taking part in the International Clean Hospitals Day Conference in Geneva, Switzerland, on October 20, 2022.
Making sure the most appropriate products can be made available on the market for health care facilities is key to ensuring safety for users and the environment. This is the primary objective of the European Biocide Product Regulation (BPR) regulations. The industry is working extremely hard to meet requirements and future proof a portfolio of products for health care to clean and disinfect their facilities.
The International Clean Hospitals Day Conference, which took place in Geneva on October 20, 2022, is an ideal opportunity for environmental hygiene industry experts to share knowledge and expertise on these regulations. The objectives we all hope to meet at the conference is to build a common understanding of how our industry ensures products have a high level of efficacy against microbes, have passed extensive toxicological and ecotoxicological exposure assessments, and fulfil the highest safety standards, ensuring the highest level of protection to human health and the environment. It is key that health care facilities understand these regulations and seek to ensure that the products they choose meet these requirements and are properly registered. The BPR regulations offers a harmonized approach to setting standards for microbial efficacy which provides assurance that disinfectant products are effective against microbes that cause health care-associated infections (HAIs) and provides guidance on use of safe active ingredients. Industry can support these facilities to choose BPR registered disinfectant products for use for the appropriate applications, ensuring a safe environment for patient, staff, and visitors.
In a session bringing together health care environmental hygiene industry leaders, Ecolab, Diversey, and GAMA Healthcare, we will discuss the impact of such regulations for both healthcare facilities and industry. There is little awareness of regulations such as BPR in health care facilities, and as it something we are very much involved in, the aim of this session at the conference is to highlight how the requirements have changed for products and how to understand product regulation status from the label.
Ecolab is a proud member and supporter of the Clean Hospitals Initiative and share a common goal to protect patients, environmental service workers, health care workers, and the natural environment through improved environmental hygiene.
The author isresponsible for Real World Evidence (RWE) and Clinical Affairs for Ecolab’s Healthcare Division. In that role she have been involved in the provision of Infection Prevention solutions to Healthcare facilities for over 20 years with Ecolab. The author leads the collection of scientific data, RWE and clinical practices that support Ecolab’s programs and works to empower education, practical knowledge, and best practices in infection prevention.
At the International Clean Hospitals Day Conference, the author spoke alongside Claire Khosravi from Diversey and Karen Wares from GAMA Healthcare on “Evolutions of biocide standards, and regulations; a few clouds on the horizon?”
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.